- Home
- CYTH vs KNW Comparison
CYTH vs KNW Comparison
Compare CYTH & KNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTH
- KNW
- Stock Information
- Founded
- CYTH 1990
- KNW 1998
- Country
- CYTH United States
- KNW United States
- Employees
- CYTH N/A
- KNW N/A
- Industry
- CYTH Biotechnology: Pharmaceutical Preparations
- KNW Industrial Machinery/Components
- Sector
- CYTH Health Care
- KNW Industrials
- Exchange
- CYTH Nasdaq
- KNW Nasdaq
- Market Cap
- CYTH 22.0M
- KNW 28.6M
- IPO Year
- CYTH N/A
- KNW N/A
- Fundamental
- Price
- CYTH $0.81
- KNW $0.19
- Analyst Decision
- CYTH Buy
- KNW Buy
- Analyst Count
- CYTH 3
- KNW 1
- Target Price
- CYTH $0.95
- KNW $1.00
- AVG Volume (30 Days)
- CYTH 32.7K
- KNW 413.8K
- Earning Date
- CYTH 11-12-2024
- KNW 12-17-2024
- Dividend Yield
- CYTH N/A
- KNW N/A
- EPS Growth
- CYTH N/A
- KNW N/A
- EPS
- CYTH N/A
- KNW N/A
- Revenue
- CYTH $1,132,430.00
- KNW N/A
- Revenue This Year
- CYTH N/A
- KNW N/A
- Revenue Next Year
- CYTH $24.49
- KNW N/A
- P/E Ratio
- CYTH N/A
- KNW N/A
- Revenue Growth
- CYTH 24.65
- KNW N/A
- 52 Week Low
- CYTH $0.59
- KNW $0.18
- 52 Week High
- CYTH $2.12
- KNW $0.94
- Technical
- Relative Strength Index (RSI)
- CYTH 57.39
- KNW 27.41
- Support Level
- CYTH $0.75
- KNW $0.18
- Resistance Level
- CYTH $0.80
- KNW $0.23
- Average True Range (ATR)
- CYTH 0.06
- KNW 0.02
- MACD
- CYTH 0.01
- KNW -0.01
- Stochastic Oscillator
- CYTH 100.00
- KNW 11.58
About CYTH Cyclo Therapeutics Inc.
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.
About KNW Know Labs Inc.
Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.